Passa al contenuto
Merck

Establishment and Long-Term Culture of Organoids Derived from Human Biliary Tract Carcinoma.

STAR protocols (2020-10-29)
Yoshimasa Saito, Toshihide Muramatsu, Hidetsugu Saito
ABSTRACT

This protocol is a procedure for establishment and culture of cancer and non-cancer organoids using tissues from biliary tract carcinoma (BTC) patients. These BTC organoids can be used for various biological analyses and drug screening. One challenge in establishing and culturing BTC organoids is non-cancer cells contaminating surgically resected tumor tissues form organoids concurrently with cancer organoids. Careful validation that the established organoids are cancer-derived is important. For complete details on the use and generation of this protocol, please refer to Saito et al. (2019) in the journal Cell Reports.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
N-acetil-L-cisteina, suitable for cell culture, BioReagent
Sigma-Aldrich
Nicotinamide, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Collagenasi, Type XI, 2-5 FALGPA units/mg solid, ≥800 CDU/mg solid
Sigma-Aldrich
[Leu15]-Gastrin I human, ≥95% (HPLC)